Pharming (PHAR) Receivables - Net (2019 - 2025)

Pharming's Receivables - Net history spans 7 years, with the latest figure at $54.7 million for Q4 2025.

  • Quarterly results put Receivables - Net at $54.7 million for Q4 2025, changed 0.22% from a year ago — trailing twelve months through Dec 2025 was $54.7 million (changed 0.22% YoY), and the annual figure for FY2025 was $54.7 million, changed 0.22%.
  • Receivables - Net for Q4 2025 was $54.7 million at Pharming, roughly flat from $54.8 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $54.8 million in Q4 2024 to a low of $27.6 million in Q4 2022.
  • The 5-year median for Receivables - Net is $46.2 million (2023), against an average of $42.7 million.
  • The sharpest move saw Receivables - Net fell 13.98% in 2021, then surged 67.12% in 2023.
  • Year by year, Receivables - Net stood at $30.0 million in 2021, then fell by 7.88% to $27.6 million in 2022, then surged by 67.12% to $46.2 million in 2023, then increased by 18.77% to $54.8 million in 2024, then decreased by 0.22% to $54.7 million in 2025.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $54.7 million, $54.8 million, and $46.2 million for Q4 2025, Q4 2024, and Q4 2023 respectively.